Cargando…

Genetic Associations of Interleukin-related Genes with Graves’ Ophthalmopathy: a Systematic Review and Meta-analysis

Graves’ ophthalmopathy (GO) is the commonest extra-thyroidal manifestation of Graves’ disease (GD). Associations between interleukin-related (IL) gene polymorphisms and GO have been reported in different populations. We aim to confirm such associations by conducting a meta-analysis. Totally 382 publ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Kah Hie, Rong, Shi Song, Chong, Kelvin K. L., Young, Alvin L., Pang, Chi Pui, Chen, Li Jia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649612/ https://www.ncbi.nlm.nih.gov/pubmed/26578206 http://dx.doi.org/10.1038/srep16672

Ejemplares similares

Autophagy in graves’ ophthalmopathy
por: Chen, Yu-Qing, et al.
Publicado: (2023)

Tear-derived exosomal biomarkers of Graves’ ophthalmopathy
por: Shi, Ting-Ting, et al.
Publicado: (2022)

Immunological Aspects of Graves' Ophthalmopathy
por: Łacheta, Dominika, et al.
Publicado: (2019)

Corticosteroids for Graves' Ophthalmopathy: Systematic Review and Meta-Analysis
por: Tu, Xiaofang, et al.
Publicado: (2018)

The Role of Interleukin-17A and NLRP3 Inflammasome in the Pathogenesis of Graves’ Ophthalmopathy
por: Lin, Chih-Chung, et al.
Publicado: (2023)

The Influence of Juvenile Graves' Ophthalmopathy on Graves' Disease Course
por: Jankauskiene, Jurate, et al.
Publicado: (2017)

Simultaneous induction of Graves’ hyperthyroidism and Graves’ ophthalmopathy by TSHR genetic immunization in BALB/c mice
por: Xia, Nan, et al.
Publicado: (2017)

Genetic associations of the thyroid stimulating hormone receptor gene with Graves diseases and Graves ophthalmopathy: A meta-analysis
por: Xiong, Haibo, et al.
Publicado: (2016)

Current insights of applying MRI in Graves’ ophthalmopathy
por: Song, Cheng, et al.
Publicado: (2022)

Graves' Ophthalmopathy: A Review of Immunogenetics
por: Khalilzadeh, Omid, et al.
Publicado: (2011)

Update on the medical treatment of Graves’ ophthalmopathy
por: Griepentrog, Gregory J, et al.
Publicado: (2009)

Radiotherapy in the treatment of Graves ophthalmopathy—to do it or not?
por: Zygulska, Aneta
Publicado: (2009)

Graves’ Ophthalmopathy Misdiagnosed as Relapsing Conjunctivitis
por: Chatziralli, Irini P., et al.
Publicado: (2010)

Imaging Evaluation of the Orbit in Graves Ophthalmopathy
por: SAS, T.N., et al.
Publicado: (2015)

Precision Medicine in Graves’ Disease and Ophthalmopathy
por: Elia, Giusy, et al.
Publicado: (2021)

Graves’ Ophthalmopathy in the Setting of Primary Hypothyroidism
por: Alajmi, Sarah, et al.
Publicado: (2022)

Orbital endoscopic decompression in Graves Ophthalmopathy
por: Lima, Wilma Terezinha Anselmo, et al.
Publicado: (2015)

Common Immunosuppressive Monotherapy for Graves’ Ophthalmopathy: A Meta-Analysis
por: Mou, Pei, et al.
Publicado: (2015)

Intravenous Glucocorticoid Treatment for Korean Graves' Ophthalmopathy Patients
por: Ahn, Hwa Young, et al.
Publicado: (2020)

Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease
por: Jarusaitiene, Dalia, et al.
Publicado: (2016)

Comparative Evaluation of Oculometric Variables in Graves’ Ophthalmopathy
por: Miot, Hélio Amante, et al.
Publicado: (2009)

Severe Grave's Ophthalmopathy–missed for many years
por: Wani, Mohd Maqbool, et al.
Publicado: (2010)

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy
por: Tabasum, Arshiya, et al.
Publicado: (2016)

The association of carotid cavernous fistula with Graves’ ophthalmopathy
por: Celik, Ozlem, et al.
Publicado: (2013)

The Influence of Prior Hyperthyroidism on Euthyroid Graves' Ophthalmopathy
por: Termote, Karolien, et al.
Publicado: (2014)

The Potential Role of Osteopontin in the Pathogenesis of Graves’ Ophthalmopathy
por: Lou, Heng, et al.
Publicado: (2021)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

The Role of Oxidative Stress and Therapeutic Potential of Antioxidants in Graves’ Ophthalmopathy
por: Hou, Tzu-Yu, et al.
Publicado: (2021)

Graves’ Ophthalmopathy as an Indication Increased the Risk of Hypoparathyroidism After Bilateral Thyroidectomy
por: Wong, Kai-Pun, et al.
Publicado: (2011)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020)

Association of variant on the promoter of cluster of differentiation 74 in graves disease and graves ophthalmopathy
por: Liu, Yu-Huei, et al.
Publicado: (2020)

Associations of CTLA4 Gene Polymorphisms with Graves' Ophthalmopathy: A Meta-Analysis
por: Du, Pengfei, et al.
Publicado: (2014)

Monoclonal antibodies for the treatment of Graves’ ophthalmopathy: A systematic review and meta-analysis
por: Fatani, Wed A., et al.
Publicado: (2023)

Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management
por: Barrio-Barrio, Jesús, et al.
Publicado: (2015)

The Evolving Role of Selenium in the Treatment of Graves' Disease and Ophthalmopathy
por: Duntas, Leonidas H.
Publicado: (2012)

Increased serum VEGF and b-FGF in Graves’ ophthalmopathy
por: Ye, Xiaozhen, et al.
Publicado: (2014)

Adiponectin concentration in the orbital fat of patients with Graves’ ophthalmopathy
por: Soiberman, Uri, et al.
Publicado: (2013)

The relationship between Graves’ ophthalmopathy and dry eye syndrome
por: Selter, Jessica H, et al.
Publicado: (2014)

Serum Cystatin C Concentrations in Patients with Graves’ Ophthalmopathy
por: Can, Nagehan, et al.
Publicado: (2020)

Evaluation of the Effect of Proptosis on Choroidal Thickness in Graves’ Ophthalmopathy
por: Yıldırım, Gamze, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8dmdpl1gbck1g3poihoa5i1tio